Neuroscience: The fragile X factor
Nature Communications
September 26, 2012
An absence of neuronal endocannabinoid signalling contributes to the behavioural and neurophysiological defects that are associated with fragile X syndrome - a common genetic cause of autism. The findings, reported in Nature Communications this week, provide new insights into the neurobiology of a disorder which is still poorly understood.
Fragile X syndrome - the most commonly inherited form of mental disability - is a major cause of autism spectrum disorder and is associated with a spectrum of mild-to-severe physical, intellectual and emotional symptoms. The main therapeutic strategies that are currently pursued by researchers involve enhancing glutamate-mediated synaptic plasticity. Glutamate signalling is known to be coupled to endocannabinoid signaling during normal functioning, however Oliver Manzoni and colleagues study a mouse model of fragile X syndrome and find that the endocannabinoid-glutamate signalling complex is uncoupled in these mice. They conclude that this uncoupling is responsible for the behavioural and neurophysiological effects associated with the disorder.
The authors suggest that their findings may provide the basis for creating novel therapeutic compounds.
doi: 10.1038/ncomms2045
Research highlights
-
Jul 1
Space health: The path of most resistance could help limit bone loss during spaceflightScientific Reports
-
Jul 1
Criminology: Predicting police enforcement bias in major US citiesNature Human Behaviour
-
Jul 1
Evolution: Pandas gave bamboo the thumbs up at least six million years agoScientific Reports
-
Jun 30
Genomics: Gray wolf genome hints at dual ancestry of dogsNature
-
Jun 30
Evolution: Hawks learn on the fly to swoop up before perchingNature
-
Jun 30
Microbiology: Transmission of gastrointestinal viruses in salivaNature